Analyze Diet
Rapid communications in mass spectrometry : RCM2011; 25(5); 585-598; doi: 10.1002/rcm.4893

Analysis of bioactive eicosanoids in equine plasma by stable isotope dilution reversed-phase liquid chromatography/multiple reaction monitoring mass spectrometry.

Abstract: Oxidative metabolites of arachidonic acid (AA) are implicated in inflammation. Thus, we evaluated cycloxygenases (COXs) and lipoxygenases (LOs) mediated metabolism of AA to eicosanoids in equine plasma. Eicosanoids were extracted from plasma by two liquid-liquid extraction (LLE) steps; first was by chloroform/isopropanol and second by methyl-tert-butyl ether. For identification and quantification of 25 eicosanoids, a highly specific, selective and sensitive stable isotope dilution liquid chromatography (LC) multiple reaction monitoring (MRM) mass spectrometric (MS) method was developed. To avoid artifact formation of eicosanoids, deferoxamine was added to plasma to chelate residual transition metal ions. The calibration curve showed excellent linearity within 0.1 to 10 ng/mL. Slopes of the calibration curves generated by adding known quantities of eicosanoids in plasma were higher than those prepared in methanol/mobile phase A. Addition of deferoxamine decreased the slope of calibration curves generated using plasma. Limit of detection (LOD) was 1-10 pg on-column for 25 different eicosanoids. Inter-day accuracy was 86-111%, whereas intra-day accuracy was from 88-110%, and precision did not exceed 15% for all quality control (QC) samples. To evaluate the formation of eicosanoids, AA was exogenously added or endogenous AA was released from esterified lipids by calcium ionophore (CI) A23187 treatment of equine whole blood. Pre-treatment of equine whole blood with dexamethasone (DEX) significantly inhibited AA or CI A23187- mediated formation of eicosanoids. The validated method is now employed in studies undertaken to better understand the mechanism of action and pharmacokinetics/pharmacodynamics of eicosanoids after administration of glucocorticoids to horses. This method is reliably reproducible.
Publication Date: 2011-02-04 PubMed ID: 21290445DOI: 10.1002/rcm.4893Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article explores an examination method for understanding the influence of arachidonic acid (AA) metabolites in inflammation. Particularly, the study focuses on the formation of eicosanoids, derivative compounds of AA thought to contribute to inflammation. A new analytical approach involving liquid chromatography and mass spectrometry was developed and used to detect and quantify these compounds in horse plasma.

Research Methodology

  • The researchers investigated how cycloxygenases (COXs) and lipoxygenases (LOs), both of which are enzymes, metabolize arachidonic acid (AA) into eicosanoids in horse plasma.
  • To extract eicosanoids from the plasma, two liquid-liquid extraction steps were employed, involving the use of chloroform/isopropanol and methyl-tert-butyl ether.
  • A unique analysis technique combining stable isotope dilution with liquid chromatography (LC) and multiple reaction monitoring (MRM) mass spectrometric (MS) method was developed.
  • To prevent artificial formation of eicosanoids due to potentially remaining traces of metal ions, a compound named deferoxamine was introduced to the plasma.

Results

  • The researchers found excellent linearity in the calibration curve within the 0.1 to 10 ng/mL range, suggesting accurate results.
  • The limit of detection (LOD) for the method ranged from 1 to 10 pg on-column for different eicosanoids, indicating high sensitivity.
  • The technique demonstrated good inter-day and intra-day accuracy and precision.
  • The formation of eicosanoids was tested using exogenous AA or by releasing endogenous AA from esterified lipids through treatment with calcium ionophore (CI) A23187 in horse blood.
  • Dexamethasone, a type of glucocorticoid, significantly inhibited the formation of eicosanoids when applied to horse blood prior to the administration of AA or CI A23187.

Conclusion

  • The method created by the researchers proved to be specific, selective, and sensitive enough to determine and identify 25 different eicosanoids.
  • The research indicates a potential role for glucocorticoids in the control or mitigation of inflammatory responses caused by the formation of eicosanoids.
  • As a result, the validated method is being used in ongoing studies to further explore the mechanisms of action and the pharmacokinetics/pharmacodynamics of eicosanoids post-glucocorticoids administration in horses.
  • This research lays important foundation for future studies focused on understanding the contribution of eicosanoids to inflammation in horses and potentially other animals and humans.

Cite This Article

APA
Mangal D, Uboh CE, Soma LR. (2011). Analysis of bioactive eicosanoids in equine plasma by stable isotope dilution reversed-phase liquid chromatography/multiple reaction monitoring mass spectrometry. Rapid Commun Mass Spectrom, 25(5), 585-598. https://doi.org/10.1002/rcm.4893

Publication

ISSN: 1097-0231
NlmUniqueID: 8802365
Country: England
Language: English
Volume: 25
Issue: 5
Pages: 585-598

Researcher Affiliations

Mangal, Dipti
  • University of Pennsylvania School of Veterinary Medicine, New Bolton Center Campus, Kennett Square, 19348, USA.
Uboh, Cornelius E
    Soma, Lawrence R

      MeSH Terms

      • Animals
      • Calibration
      • Chemical Fractionation
      • Chromatography, Reverse-Phase / methods
      • Eicosanoids / blood
      • Eicosanoids / metabolism
      • Horses
      • Isotope Labeling / methods
      • Linear Models
      • Mass Spectrometry / methods
      • Reproducibility of Results
      • Sensitivity and Specificity

      Citations

      This article has been cited 4 times.
      1. Tou K, Cawley A, Bowen C, Bishop DP, Fu S. Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-Doping. Molecules 2022 Dec 30;28(1).
        doi: 10.3390/molecules28010312pubmed: 36615506google scholar: lookup
      2. Auguet T, Aragonès G, Colom M, Aguilar C, Martín-Paredero V, Canela N, Ruyra X, Richart C. Targeted metabolomic approach in men with carotid plaque. PLoS One 2018;13(7):e0200547.
        doi: 10.1371/journal.pone.0200547pubmed: 30011297google scholar: lookup
      3. Knych HK. Administration Studies in Equine Antidoping Research: Designing Scientific Investigations to Effectively Direct Medication Control in Racehorses. Drug Test Anal 2025 Sep;17(9):1560-1566.
        doi: 10.1002/dta.3857pubmed: 39876751google scholar: lookup
      4. Tou K, Cawley A, Noble G, Loy J, Bishop D, Keledjian J, Sornalingam K, Richards S, Fu S. Lipid and Corticosteroid Biomarkers Under the Influence of Bisphosphonates. Drug Test Anal 2025 Jul;17(7):1107-1117.
        doi: 10.1002/dta.3811pubmed: 39407358google scholar: lookup